US Pre-Market SEC Filings Roundup — February 17, 2026

18-02-2026

Marvell Technology, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-055923), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, period-over-period changes, positive or negative performance indicators, or other material facts are available.

18-02-2026

FRESH DEL MONTE PRODUCE INC filed an 8-K on 2026-02-18 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other metrics are disclosed in the provided filing details. This is an informational disclosure typical for earnings releases.

18-02-2026

Innospec Inc. filed a Form 8-K on 2026-02-18 (AccNo: 0001193125-26-055921, Size: 452 KB) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data were mentioned in the provided filing details. This is a multi-item mandatory filing typical for earnings releases.

18-02-2026

Western Digital Corp filed a Form 8-K on 2026-02-18 under Item 3.03, disclosing material modifications to the rights of security holders. No specific details on the nature of the modifications, dollar values, financial impacts, or strategic rationale are provided. This requires review of the full filing for complete assessment.

18-02-2026

Galera Therapeutics, Inc. filed a Form 8-K on February 18, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 reports financial statements and exhibits. No financial metrics, transaction details, or specific impacts are disclosed.

18-02-2026

CareTrust REIT, Inc. filed a Form 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details regarding the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics, period-over-period comparisons, or forward-looking guidance provided.

• ·Accession Number: 0001140361-26-005889
• ·Filing size: 845 KB

18-02-2026

News Corp filed a Form 8-K on February 18, 2026 (AccNo: 0001564708-26-000036, Size: 399 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or metrics are disclosed. This is a multi-item, likely voluntary disclosure with no directional financial impact provided.

18-02-2026

USANA Health Sciences Inc. filed an 8-K on February 18, 2026 (AccNo: 0000896264-26-000014), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing excerpt. No positive or negative performance details, period-over-period comparisons, or strategic updates are disclosed.

18-02-2026

urban-gro, Inc. filed an 8-K on 2026-02-18 reporting under Item 1.01 its entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, indicating potential strategic or financing activity. However, no details on transaction size, terms, parties, financial impact, or dilution effects are disclosed. This multi-item filing is informational without quantified metrics.

• ·AccNo: 0001213900-26-017595
• ·File size: 203 KB

18-02-2026

Hormel Foods Corp /DE/ filed a Form 8-K on February 18, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results with no detailed quantitative data available.

18-02-2026

18-02-2026

OGE Energy Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-055417), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or other quantitative data are disclosed in the provided filing information. This represents a standard earnings-related disclosure without detailed performance indicators.

18-02-2026

J&J Snack Foods Corp filed an 8-K on February 18, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders. No specific proposals, vote outcomes, or numerical results are disclosed in the filing information provided. This is a routine disclosure of shareholder meeting results with no financial metrics or directional implications mentioned.

18-02-2026

SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017657), disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and timing are NOT_DISCLOSED. No financial metrics, performance comparisons, or other quantitative data are provided in the filing summary.

• ·File size: 186 KB

18-02-2026

The company filed a Form 8-K on February 18, 2026 (AccNo: 0000950103-26-002247, Size: 17 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, events, financial metrics, or transactions provided in the filing summary. No quantitative data, period-over-period comparisons, or named entities are explicitly stated.

18-02-2026

Constellium SE filed an 8-K on February 18, 2026, under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing details. This appears to be a single-item mandatory filing for financial results with no quantitative data extracted.

18-02-2026

Bluejay Diagnostics, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017641, size 225 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item informational filing without detailed content available.

• ·Filing Accession Number: 0001213900-26-017641
• ·Sector: not specified

18-02-2026

Bubblr Inc. filed a Form 8-K on 2026-02-18 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar amounts, percentages, or other quantitative data disclosed. This represents a material negative event with no offsetting positive disclosures.

18-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-18 disclosing Item 1.01 Entry into a Material Definitive Agreement related to a merger/acquisition, Item 5.03 Amendments to Articles of Incorporation or Bylaws or Change in Fiscal Year, Item 5.07 Submission of Matters to a Vote of Security Holders, and Item 9.01 Financial Statements and Exhibits. No quantitative metrics, deal terms, parties beyond the filer, valuations, or performance comparisons are explicitly stated. No positive or negative metrics are present to report.

18-02-2026

HF Sinclair Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position, reason for change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics, comparisons, or impacts are mentioned.

18-02-2026

Travel & Leisure Co. filed an 8-K on February 18, 2026 (AccNo: 0001361658-26-000005), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details. No positive or negative performance indicators are mentioned.

18-02-2026

Energy Vault Holdings, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001104659-26-016759), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

18-02-2026

Cinemark Holdings, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. All transaction values, percentages, and operational data are NOT_DISCLOSED.

18-02-2026

GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.

18-02-2026

Moody's Corp /DE/ filed an 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

18-02-2026

Hycroft Mining Holding Corp filed a Form 8-K on February 18, 2026 (AccNo: 0001493152-26-007255, Size: 43 MB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely including voluntary disclosures of material information and exhibits such as press releases or presentations. No specific details on events, transactions, financial metrics, or impacts are disclosed in the provided filing summary.

18-02-2026

Insulet Corp filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing details. No positive or negative performance indicators, period-over-period comparisons, or strategic updates are explicitly stated.

18-02-2026

Palladyne AI Corp. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, or any financial metrics are disclosed. Sector not specified.

18-02-2026

Philip Morris International Inc. filed an 8-K on February 18, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details on the content of the Regulation FD disclosure are missing.

18-02-2026

Analog Devices Inc filed an 8-K on February 18, 2026 (AccNo: 0000006281-26-000015), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or transaction values were mentioned.

18-02-2026

Bausch & Lomb Corp filed a Form 8-K on 2026-02-18 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics were mentioned in the filing details provided. This appears to be a standard mandatory earnings-related disclosure without quantified performance data available.

18-02-2026

DANA Inc filed an 8-K on 2026-02-18 disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results announcement, with attached documents in a 10 MB filing (AccNo: 0001193125-26-056030). No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided information.

18-02-2026

Garmin Ltd filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056025), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional financial data available.

18-02-2026

NewAmsterdam Pharma Co N.V. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-056020), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics are available for analysis.

18-02-2026

ONESPAWORLD HOLDINGS Ltd filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056024), reporting under Item 2.02 for Results of Operations and Financial Condition, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure without detailed performance data.

18-02-2026

Utz Brands, Inc. filed an 8-K on February 18, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary disclosure of material non-public information with attached exhibits. No specific financial metrics, transactions, quantitative data, positive or negative changes, or operational details were disclosed in the provided filing information.

18-02-2026

OPENLANE, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001395942-26-000005), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard multi-item earnings-related filing. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are detailed in the provided filing information.

18-02-2026

SSR Mining Inc. filed a Form 8-K on February 18, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits disclosed. No financial metrics, transactions, or directional impacts are provided.

18-02-2026

Granite Construction Inc filed an 8-K on February 18, 2026 (AccNo: 0000861459-26-000006), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 1.03 (Bankruptcy or Receivership), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a core bankruptcy-related event with no specific financial metrics, transaction values, or quantitative impacts provided. No positive metrics were mentioned, highlighting severe financial distress.

18-02-2026

Vita Coco Company, Inc. filed a Form 8-K on February 18, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be an informational earnings-related disclosure without detailed performance data.

18-02-2026

Enpro Inc. filed an 8-K on 2026-02-18 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. Sector is not specified.

18-02-2026

Verisk Analytics, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the filing summary provided.

18-02-2026

Pinterest, Inc. filed an 8-K on February 18, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are disclosed in the filing information provided. No positive or negative performance indicators, scheduled events, or strategic updates are mentioned.

18-02-2026

Mister Car Wash, Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation), Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a comprehensive voluntary and mandatory disclosure covering operational results, agreements, and governance matters.

18-02-2026

Charles River Laboratories International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001100682-26-000020), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard voluntary earnings disclosure filing, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. No positive, negative, or flat performance indicators are available.

18-02-2026

LCI Industries filed an 8-K on February 18, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other metrics in the available information. No positive or negative performance details, guidance, or comparisons are mentioned.

18-02-2026

Upwork, Inc. filed a Form 8-K on February 18, 2026, under Item 8.01 (Other Events), indicating a voluntary disclosure of an unspecified event. No financial metrics, transaction details, positive or negative changes, or quantitative data are disclosed in the provided filing information. This single-item filing provides no directional insights into company performance.

18-02-2026

enCore Energy Corp. filed an 8-K on February 18, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of material information to comply with Regulation FD, with exhibits attached. No specific financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the filing summary.

18-02-2026

SolarEdge Technologies, Inc. filed a Form 8-K on 2026-02-18 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

• ·AccNo: 0001178913-26-000558
• ·Filing size: 1 MB

18-02-2026

TripAdvisor, Inc. filed a Form 8-K on February 18, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing metadata. This appears to be an informational filing without quantified impacts.

18-02-2026

Cencora, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001104659-26-016785, Size: 315 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosures and attached exhibits, but no specific events, transactions, or metrics are detailed in the provided summary. No quantitative financial data, positive or negative performance indicators, or material impacts are disclosed.

18-02-2026

Jones Lang LaSalle Inc filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided information. This is a standard voluntary earnings-related filing with no period-over-period comparisons or guidance mentioned.

18-02-2026

CREATIVE REALITIES, INC. filed an 8-K on February 18, 2026 (AccNo: 0001437749-26-004453), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

18-02-2026

Wingstop Inc. filed an 8-K on February 18, 2026, disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related multi-item filing with no directional performance data available.

18-02-2026

Sabre Corp filed a Form 8-K on 2026-02-18 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics are mentioned. This appears to be a standard voluntary earnings-related disclosure with attached exhibits.

18-02-2026

Bread Financial Holdings, Inc. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. No financial details, transaction values, or impacts are disclosed. No quantitative metrics or period-over-period comparisons are provided.

18-02-2026

TLGY Acquisition Corp filed an 8-K on 2026-02-18 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), related to a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial metrics, strategic rationale, or shareholder impacts are disclosed in the filing metadata provided. Sector details are not specified.

18-02-2026

Ankam, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

18-02-2026

Kraft Heinz Co filed an 8-K on February 18, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, nature of change (appointment or resignation), reasons, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative governance implications, board outcomes, or market impacts can be assessed due to lack of details.

18-02-2026

JBT Marel Corp filed an 8-K on February 18, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing summary.

18-02-2026

Avalon GloboCare Corp. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017682, Size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing involves a voluntary disclosure of material nonpublic information with attached exhibits. No financial metrics, transactions, or specific details are provided in the filing summary.

• ·File size: 222 KB
• ·Accession Number: 0001213900-26-017682

18-02-2026

Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.

18-02-2026

Theriva Biologics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item mandatory and voluntary filing, but no details on the agreement's nature, parties, value, or financial impacts are provided in the available information. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

• ·AccNo: 0001104659-26-016792
• ·Filing size: 677 KB

18-02-2026

Innventure, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0002001557-26-000024, Size: 176 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, transaction values, financial metrics, or exhibits provided. No quantitative data, performance metrics, positives, negatives, or comparisons are mentioned.

18-02-2026

i-80 Gold Corp. filed a Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details regarding the nature of the agreement, disclosures, events, transaction values, financial impacts, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

18-02-2026

PROG Holdings, Inc. filed a Form 8-K on February 18, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are detailed in the provided filing information. This is a standard multi-item earnings-related disclosure with no indicated positive or negative performance variations.

18-02-2026

Moleculin Biotech, Inc. filed a Form 8-K on February 18, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, transaction values, financial metrics, or performance changes provided. No quantitative data, positive or negative metrics, or period-over-period comparisons were mentioned.

18-02-2026

IMAC Holdings, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

18-02-2026

Tarsus Pharmaceuticals, Inc. disclosed an officer change via 8-K filing on February 18, 2026, under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or terms are disclosed.

18-02-2026

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a Form 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics provided. No performance metrics, positive or negative changes, or period-over-period comparisons were mentioned.

18-02-2026

Aprea Therapeutics, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001104659-26-016797, size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, transaction, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, positive or negative changes, or comparisons are mentioned.

18-02-2026

La Rosa Holdings Corp. filed a Form 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed. This multi-item filing signals material developments but lacks quantitative context for assessment.

18-02-2026

Sonic Automotive Inc filed an 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the filing details provided. This is a multi-item filing focused on earnings release with no directional financial data available.

18-02-2026

Sintx Technologies, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons, or timing were disclosed.

• ·AccNo: 0001493152-26-007271
• ·File Size: 367 KB
• ·Sector: NOT_DISCLOSED

18-02-2026

Sensei Biotherapeutics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), departures or elections of directors and officers along with compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01); no quantitative financial metrics, deal terms, or performance comparisons were detailed.

18-02-2026

MFA Financial, Inc. filed a Form 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition and Item 7.01 for Regulation FD Disclosure. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing information. No quantitative financial metrics or directional performance indicators (positive, negative, or flat) are disclosed.

18-02-2026

Tharimmune, Inc. filed a Form 8-K on February 18, 2026, under Item 5.03 disclosing amendments to Articles of Incorporation or Bylaws or a change in fiscal year, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of amendments, disclosures, or exhibits are provided. No financial metrics, transactions, or impacts are mentioned.

18-02-2026

Liberty Global Ltd. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

18-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on February 18, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details on the disclosures, events, financial metrics, or impacts are provided in the filing metadata.

18-02-2026

QT Imaging Holdings, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings announcements.